- Filed
- Mar 17, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 13, 2025 | 25.31M sh |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $12.77M |
| Short Term Debt | FY 2024 · Dec 31, 2023 | $146K |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | −$160.33M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $255.9M |
| Current Assets | FY 2024 · Dec 31, 2023 | $112.42M |
| Total Assets | FY 2024 · Dec 31, 2023 | $313.91M |
| Shares Diluted restated | FY 2024 · Dec 31, 2022 | 14.09M sh |
| Capex | FY 2024 · Dec 31, 2022 | $53.06M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$175.37M |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $178.67M |
| Eps Diluted restated | FY 2024 · Dec 31, 2022 | −$15.64 |
| Eps Basic restated | FY 2024 · Dec 31, 2022 | −$15.64 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $81.01M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $186.69M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$179.43M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $10.57M |
| Revenue | FY 2024 · Dec 31, 2022 | $98.02M |